Eligibility for Anti-Amyloid Treatment
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment.
Read the related article in Neurology.
Visit NPub.org/Podcast for associated article links.
You May Also Like

Your Daily Dose
Dr Len Brancewicz, RPh, NMD

Meditation for Anxiety
Anxiety
दिनभर: पूरा दिन,पूरी ख़बर (Dinbhar)
BBC Hindi Radio

Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio

The Real Truth About Health Free 17 Day Live Online Conference Podcast
Lloyd Burrell, Keith Block M.D., Jeffrey Smith, Michael Klaper M.D., Ralph Moss, Brenda Davis R.D., Mark Sloan, Gerald Posner, Ian Harris M.D., Neil Barnard M.D., Will Tuttle Ph.D., John McDougall M.D., Pam Popper Ph.D., Gabriel Cousens M.D., Brian Clement Ph.D., Anna Maria Clement Ph.D., Marianne W

Erotic Short Stories: Read by Mia Hart
Sexuality and Erotica

I Choose Me with Jennie Garth
iHeartPodcasts

Savage Lovecast
Dan Savage

Dr. Derek Suite - The Suite Spot
Derek H. Suite, M.D.

The Ultimate Intimacy Podcast
Nick and Amy with The Ultimate Intimacy App
Community discussion